Please assess the completion status of the following clinical trial:

Trial Title: To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with primary hypercholesterolemia~Exclusion Criteria:~* The subject not meet the specified LDL-C level

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- Livalo 2mg, Ezetrol 10mg (Type: EXPERIMENTAL): Pitavastatin 2mg, Ezetimibe 10mg
- Livalo 2mg (Type: ACTIVE_COMPARATOR): Pitavastatin 2mg
- Livalo 4mg, Ezetrol 10mg (Type: EXPERIMENTAL): Pitavastatin 4mg, Ezetimibe 10mg
- Livalo 4mg (Type: ACTIVE_COMPARATOR): Pitavastatin 4mg

Based on this trial design, predict the completion outcome and termination type (if applicable).